GOVX Insider Trading Activity and SEC Form 4 Filings
GOVX insider trading summary
No open-market insider purchases or sales of GeoVax Labs, Inc. (GOVX) have been reported on SEC Form 4 in the past 12 months.
Latest GOVX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 17, 2025 | John N Spencer Jr | Director | Buy | $5K (10,000 @ $0.55) |
| Aug 7, 2025 | Kelly T. McKee Jr. | Chief Medical Officer | Buy | $742 (1,107 @ $0.67) |
| Apr 10, 2025 | John W. Sharkey | VP, Business Development | Buy | $6K (6,000 @ $0.99) |
| Apr 10, 2025 | John N Spencer Jr | Director | Buy | $10K (10,000 @ $0.98) |
| Apr 1, 2025 | David A Dodd | President, CEO | Buy | $11K (10,000 @ $1.08) |
| Mar 31, 2025 | Mark Reynolds | CFO | Buy | $7K (6,800 @ $1.08) |
| Aug 9, 2024 | David A Dodd | President, CEO | Buy | $16K (8,000 @ $1.95) |
| Feb 22, 2024 | David A Dodd | President, CEO | Buy | $19K (8,209 @ $2.27) |
| Feb 21, 2024 | David A Dodd | President, CEO | Buy | $1K (520 @ $2.15) |
| Feb 7, 2024 | Mark Reynolds | CFO | Buy | $6K (2,000 @ $2.77) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.